The DME entity is offered at $74,900 and holds a three (3) year Full DME accreditation through BOC for the following product categories: DM02 (commodes, urinals, bed pans), DM05/DM06 (blood glucose monitors), M01 (canes and crutches), OR03 (non-custom braces), S01 (surgical dressings), and S02 (diabetic footwear). Additional product categories may be added as needed.

The business operates from a fully furnished office space with a transferable lease and is free of any legacy liabilities. Established lines of credit with Medicare-approved vendors and manufacturers are already in place, eliminating concerns related to prior billing audits or inventory management.

The platform is geographically flexible and fully relocatable, supporting national expansion strategies. This offering provides a clean acquisition, a compliant operational foundation, and a clear pathway to monetization, positioning the company for rapid activation and scalable growth.

Structured post-closing transition & activation support (30 days) offered as a paid add-on to help buyers avoid the risk of "learning the hard way" of early mistakes that trigger audits or denials by offering compliance guidance with BOC and CMS supplier standards, operational setup, Medicare activation oversight and revenue-readiness support.